This inventor holds 5 USPTO granted patents. Top assignee: Isis Pharmaceuticals, Inc.. Active years: 1999-2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999-2001
Title: Innovations of Shin Cheng Flournoy
Introduction
Shin Cheng Flournoy is a notable inventor based in San Diego, CA. He has made significant contributions to the field of biotechnology, particularly in the modulation of gene expression. With a total of 5 patents, his work has implications for treating various diseases.
Latest Patents
Flournoy's latest patents include groundbreaking research on antisense modulation of ADAM10 expression. This patent provides antisense compounds, compositions, and methods for modulating the expression of ADAM10, which is crucial for treating diseases associated with its expression. Another significant patent focuses on the antisense inhibition of tumor necrosis factor alpha converting enzyme (TACE) expression. This invention offers compositions and methods for inhibiting TACE expression, particularly beneficial for inflammatory and autoimmune diseases.
Career Highlights
Flournoy is currently associated with Isis Pharmaceuticals, Inc., where he continues to innovate in the field of gene therapy. His work has been instrumental in advancing therapeutic strategies that target specific gene expressions.
Collaborations
Some of his notable coworkers include C Frank Bennett and Thomas P Condon, who have collaborated with him on various projects, enhancing the impact of their research.
Conclusion
Shin Cheng Flournoy's contributions to biotechnology through his patents and collaborations highlight his role as a leading inventor in the field. His work continues to pave the way for innovative treatments for complex diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile